Understanding the risk of developing psychosis in young people in Kenya
Clinical and Biomarker-Based Trajectories of Psychosis-Risk Populations in Kenya
['FUNDING_R01'] · WASHINGTON UNIVERSITY · NIH-10901947
This study is looking at what might increase the chances of young people in Kenya developing psychosis, and it aims to find out how different backgrounds can affect this, so we can better support those at risk.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | WASHINGTON UNIVERSITY (nih funded) |
| Locations | 1 site (SAINT LOUIS, UNITED STATES) |
| Trial ID | NIH-10901947 on ClinicalTrials.gov |
What this research studies
This research investigates the risk factors and biological markers associated with the development of psychosis in adolescents and young adults in Kenya. By utilizing advanced multimodal methods, the study aims to identify individuals at clinical high risk for psychosis and predict their clinical trajectories. The research will also explore the ethnic diversity in the presentation of psychosis, which is often overlooked in existing studies. Participants may undergo assessments that include cognitive evaluations and biomarker analysis to better understand their risk profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults in Kenya who are identified as being at clinical high risk for developing psychosis.
Not a fit: Patients who are not at risk for psychosis or who are outside the adolescent and young adult age range may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early identification and intervention strategies for young people at risk of developing psychosis.
How similar studies have performed: While there have been successful studies in other regions, this research is novel as it focuses specifically on the African population, which has been underrepresented in psychosis risk research.
Where this research is happening
SAINT LOUIS, UNITED STATES
- WASHINGTON UNIVERSITY — SAINT LOUIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MAMAH, DANIEL — WASHINGTON UNIVERSITY
- Study coordinator: MAMAH, DANIEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Bipolar Disorder